MET Immunohistochemistry Should Be Avoided in Selecting Non-small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

被引：5
|
作者：
Lambros, Laetitia [1 ]
Uguen, Arnaud [1 ,2 ]
机构：
[1] CHRU Brest, Dept Pathol, Brest, France
[2] INSERM, U1053 BaRITOn, Bordeaux, France
来源：
CLINICAL LUNG CANCER | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/j.cllc.2018.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E418 / E420
页数：3
相关论文
共 50 条
  • [41] MET Exon 14 Skipping Mutation Positive Non-Small Cell Lung Cancer: A Population-Based Cohort
    Wong, S.
    Alex, D.
    Bosdet, I.
    Hughesman, C.
    Karsan, A.
    Yip, S.
    Ho, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S670 - S671
  • [42] Optimized Detection of Unknown MET Exon 14 Skipping Mutations in Routine Testing for Patients With Non-Small-Cell Lung Cancer
    Sun, Rui
    Wang, Zhizhong
    Zhao, Jiuzhou
    Ren, Pengfei
    Ma, Jie
    Guo, Yongjun
    JCO PRECISION ONCOLOGY, 2023, 7
  • [43] Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer with MET Exon 14 Skipping
    Han, Y.
    Chen, S.
    Xiang, C.
    Guo, L.
    Zhu, L.
    Shao, J.
    Hu, T.
    Wang, J.
    Zhu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S60 - S61
  • [44] Identification of a Novel MET Exon 14 Skipping Variant in Non-Small Cell Lung Cancer
    Cheng, Y.
    Das, R.
    Jakubowski, M.
    Spildener, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S89 - S89
  • [45] Comprehensive characterization of MET exon 14 skipping mutations in non-small cell lung cancer
    Wu, Xue
    Zhang, Yaru
    Pang, Jiaohui
    Lin, Li
    Yin, Jiani C.
    Tang, Haimeng
    Shao, Yang
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Caixia Ding
    Yanyi Qiu
    Juan Zhang
    Wei Wei
    Hongbian Gao
    Yong Yuan
    Xiaomin Wang
    BMC Pulmonary Medicine, 23
  • [47] Clinicopathological characteristics of Non-Small Cell Lung Cancer (NSCLC) patients with c-MET exon 14 skipping mutation, MET overexpression and amplification
    Ding, Caixia
    Qiu, Yanyi
    Zhang, Juan
    Wei, Wei
    Gao, Hongbian
    Yuan, Yong
    Wang, Xiaomin
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [48] The characteristics of MET exon 14 skipping mutations in Chinese non-small cell lung cancer: A retrospective analysis
    Zhu, Y.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    ANNALS OF ONCOLOGY, 2019, 30 : 5 - 5
  • [49] Retrospective Analysis to Optimize the Detection of MET Exon 14 Skipping Mutations in Non-Small Cell Lung Cancer
    Lu, Jang-Jih
    Tsai, Shu-Hui
    Lin, Lee-Chung
    Chiueh, Tzong-Shi
    DIAGNOSTICS, 2024, 14 (11)
  • [50] Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns
    Lee, Jessica K.
    Madison, Russell
    Classon, Anthony
    Gjoerup, Ole
    Rosenzweig, Mark
    Frampton, Garrett M.
    Alexander, Brian M.
    Oxnard, Geoffrey R.
    Venstrom, Jeffrey M.
    Awad, Mark M.
    Schrock, Alexa B.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1354 - 1376
12345